-
- EXPLORE
-
-
Global Intraoperative Radiation Therapy Market Expected to Reach USD 3.06 Billion by 2031, Driven by Increase in Targeted Cancer Surgery

[Boston, 26th June 2025] – According to Clearview Market Insights (CVMI), the global intraoperative radiation therapy (IORT) market is projected to grow from USD 1.58 billion in 2024 to USD 3.06 billion by 2031, registering a CAGR of 9.9%. The increase in IORT adoption is driven by its role in reducing treatment times, enhancing surgical oncology workflows, and protecting healthy tissue during radiation.
IORT delivers precision radiation when it matters most—during surgery—allowing better tumor control and a faster path to recovery,” said Dr. Elena Bronski, Senior Oncology Devices Analyst at CVMI.
Request Sample @ https://clearviewmarketinsights.com/report-details/global-intraoperative-radiation-therapy-market/
Key Market Insights
- 2024 Market Value: USD 1.58 billion
- 2031 Forecast: USD 3.06 billion
- CAGR: 9.9% (2024–2031)
Drivers of Growth
- Breast Cancer Dominance: Leading indication for IORT, supported by strong clinical outcomes
- Technology Innovation: Compact LINACs, 3D image guidance, and digital workflow integration
- Global Oncology Infrastructure: Government programs expanding surgical oncology in Asia and LATAM
Segment Highlights
- Top Indication: Breast cancer accounts for over 45% of IORT procedures globally
- Leading Technology: X-ray-based platforms gaining popularity in outpatient setups
- Key End Users: Specialty cancer hospitals and hybrid ORs in academic centers
Competitive Landscape (2024)
- Zeiss – 33%: INTRABEAM® continues to be a globally adopted IORT platform
- S.I.T. – 21%: European leader in electron beam therapy
- GMV – 17%: Integrated multidisciplinary radiation
- IntraOp – 14%: Mobile LINAC innovation featuring Mobetron®
- Others – 15%: Early-stage tech and region-focused suppliers
Outlook to 2031
The future of IORT will center on cost-effective platforms, cloud-based radiation dosing records, and standardized surgical-radiation protocols. Broader adoption in mid-tier hospitals, along with payer support for single-session therapy, will propel the next phase of growth.
For more insights, visit https://clearviewmarketinsights.com/
About Clearview Market Insights:
Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.
Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369